REGRANEX Gel should not be used in patients with cancers at the site of application. In a safety study, patients treated with 3 or more tubes of REGRANEX Gel had an increased risk of death from cancer at locations in the body other than the ulcer. Talk to your doctor about risks of cancer and tell your doctor if you have or have had cancer.

In clinical studies, a small percentage of patients treated with REGRANEX Gel or placebo gel experienced rash near the wound. REGRANEX Gel should not be used by patients sensitive to any components of this product. Please click here to see the Full Prescribing Information for REGRANEX Gel.

Full Prescribing Information | Media Center | Legal Notice | Privacy Policy | Contact Us | Site Map